Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 06, 2021

SELL
$29.97 - $36.66 $0 - $0
0 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$25.39 - $32.61 $0 - $0
0 New
0 $0
Q1 2021

Apr 30, 2021

BUY
$19.92 - $31.6 $0 - $0
0 New
0 $0
Q4 2020

Jan 25, 2021

BUY
$12.16 - $19.77 $0 - $0
0 New
0 $0
Q3 2020

Oct 29, 2020

BUY
$11.25 - $14.75 $0 - $0
0 New
0 $0
Q2 2020

Aug 05, 2020

BUY
$10.69 - $16.49 $0 - $0
0 New
0 $0
Q1 2020

May 12, 2020

SELL
$9.78 - $29.53 $146 - $442
-15 Closed
0 $0
Q4 2019

Jan 17, 2020

BUY
$20.93 - $35.1 $313 - $526
15 New
15 $0
Q3 2019

Nov 07, 2019

BUY
$22.08 - $47.08 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019

SELL
$26.93 - $34.7 $6,059 - $7,807
-225 Closed
0 $0
Q4 2018

Jan 23, 2019

SELL
$27.23 - $45.56 $50,892 - $85,151
-1,869 Reduced 89.26%
225 $6,000
Q3 2018

Oct 25, 2018

BUY
$37.57 - $50.34 $5,071 - $6,795
135 Added 6.89%
2,094 $0
Q2 2018

Aug 07, 2018

BUY
$27.75 - $40.17 $20,118 - $29,123
725 Added 58.75%
1,959 $0
Q1 2018

Jun 03, 2019

SELL
$28.83 - $41.01 $14,703 - $20,915
-510 Reduced 29.24%
1,234 $42,000
Q1 2018

May 09, 2018

BUY
$28.83 - $41.01 $14,703 - $20,915
510 Added 41.33%
1,744 $0
Q4 2017

Jan 24, 2018

BUY
$28.45 - $37.14 $19,488 - $25,440
685 Added 124.77%
1,234 $0
Q3 2017

Oct 30, 2017

BUY
$24.01 - $36.2 $8,403 - $12,670
350 Added 175.88%
549 $20,000
Q2 2017

Jun 03, 2019

SELL
N/A
-41 Reduced 17.08%
199 $5,000
Q4 2016

Jun 03, 2019

SELL
N/A
-630 Reduced 72.41%
240 $4,000
Q2 2016

Jun 03, 2019

BUY
N/A
870
870 $27,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.25B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.